{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:52:59Z","timestamp":1778860379891,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H03444"],"award-info":[{"award-number":["19H03444"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018736","name":"Kaken Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.prp.2023.154313","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T11:21:51Z","timestamp":1673868111000},"page":"154313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["TFE3-immunopositive papillary renal cell carcinoma: A clinicopathological, immunohistochemical, and genetic study"],"prefix":"10.1016","volume":"242","author":[{"given":"Dai","family":"Takamatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Kohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Kiyozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Ieiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9636-1182","authenticated-orcid":false,"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154313_bib1","series-title":"Papillary renal cell carcinoma. The WHO classificaion of tumours editorial board eds. WHO classification of tumours: 5th edition. Urinary and Male Genital Tumours","author":"Amin","year":"2022"},{"key":"10.1016\/j.prp.2023.154313_bib2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41379-018-0191-7","article-title":"NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma","volume":"32","author":"Pei","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00428-018-2509-8","article-title":"A novel partner of TFE3 in the Xp11 translocation renal cell carcinoma: clinicopathological analyses and detection of EWSR1-TFE3 fusion","volume":"474","author":"Fukuda","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2023.154313_bib4","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/modpathol.2011.93","article-title":"Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions","volume":"24","author":"Martignoni","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib5","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1158\/1078-0432.CCR-19-3283","article-title":"Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy-number variations as drivers of disease progression","volume":"26","author":"Marcon","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154313_bib6","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/sj.onc.1201394","article-title":"Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma","volume":"15","author":"Clark","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2023.154313_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.onc.1204074","article-title":"The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25","volume":"20","author":"Ladanyi","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2023.154313_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/PAS.0000000000000837","article-title":"Xp11 translocation Renal Cell Carcinomas (RCCs) with RBM10-TFE3 gene fusion demonstrating melanotic features and overlapping morphology with t(6;11) RCC: interest and diagnostic pitfall in detecting a paracentric inversion of TFE3","volume":"41","author":"Xia","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/PAS.0000000000000730","article-title":"TFE3-Fusion variant analysis defines specific clinicopathologic associations amog Xp11 translocation cancers","volume":"41","author":"Pivovarcikova","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib10","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1158\/1078-0432.CCR-20-3788","article-title":"Integrated molecular characterization of fumarate hydratase-deficient renal cell carcinoma","volume":"27","author":"Sun","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154313_bib11","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1158\/1078-0432.CCR-20-4367","article-title":"Comprehensive molecular characterization and response to therapy in fumarate hydratase-deficient renal cell carcinoma","volume":"27","author":"Gleeson","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2023.154313_bib12","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41379-018-0017-7","volume":"31","author":"Muller","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib13","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000719","article-title":"Tubulocystic carcinoma of the kidney with poorly differentiated foci: a frequent morphologic pattern of fumarate hydratase-deficient renal cell carcinoma","volume":"40","author":"Smith","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib14","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0000000000001476","article-title":"Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: III: molecular pathology of kidney cancer","volume":"44","author":"Williamson","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib16","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0000000000001372","article-title":"A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients","volume":"44","author":"Lau","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib18","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/hupa.2001.24984","article-title":"Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases","volume":"32","author":"Delahunt","year":"2001","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib19","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1097\/PAS.0000000000000962","article-title":"Toward biological subtyping of papillary renal cell carcinoma with clinical implications through histologic, immunohistochemical, and molecular analysis","volume":"41","author":"Saleeb","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.euf.2016.09.002","article-title":"Integrated phenotypic\/genotypic analysis of papillary renal cell carcinoma subtypes: identification of prognostic markers, cancer-related pathways, and implications for therapy","volume":"4","author":"Saleeb","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.prp.2023.154313_bib21","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0888-7543(91)90145-5","article-title":"The gene encoding human TFE3, a transcription factor that binds the immunoglobulin heavy-chain enhancer, maps to Xp11.22","volume":"11","author":"Henthorn","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.prp.2023.154313_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature14587","article-title":"Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism","volume":"524","author":"Perera","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.prp.2023.154313_bib24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/00000478-200306000-00005","article-title":"Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay","volume":"27","author":"Argani","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib25","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41379-019-0283-z","article-title":"Xp11 translocation renal cell carcinoma and clear cell renal cell carcinoma with TFE3 strong positive immunostaining: morphology, immunohistochemistry, and FISH analysis","volume":"32","author":"Yang","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Cancer Genome Atlas Research","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2023.154313_bib27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/PAS.0000000000000247","article-title":"The morphologic and immunohistochemical spectrum of papillary renal cell carcinoma: study including 132 cases with pure type 1 and type 2 morphology as well as tumors with overlapping features","volume":"38","author":"Chevarie-Davis","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/PAS.0000000000001455","article-title":"High WHO\/ISUP grade and unfavorable architecture, rather than typing of papillary renal cell carcinoma, may be associated with worse prognosis","volume":"44","author":"Yang","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAP.0000000000000341","article-title":"Updates in grading of renal cell carcinomas beyond clear cell renal cell carcinoma and papillary renal cell carcinoma","volume":"29","author":"Paner","year":"2022","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.urolonc.2021.04.013","article-title":"Papillary renal cell carcinoma: review","volume":"39","author":"Mendhiratta","year":"2021","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.prp.2023.154313_bib31","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/his.13700","article-title":"TFE3 translocation and protein expression in renal cell carcinoma are correlated with poor prognosis","volume":"73","author":"Lee","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2023.154313_bib32","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1101\/gad.228122.113","article-title":"Exploiting the bad eating habits of Ras-driven cancers","volume":"27","author":"White","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2023.154313_bib33","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.287524.116","article-title":"Recent insights into the function of autophagy in cancer","volume":"30","author":"Amaravadi","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2023.154313_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4161\/cbt.11.2.14622","article-title":"Autophagy as a therapeutic target in cancer","volume":"11","author":"Chen","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.prp.2023.154313_bib35","doi-asserted-by":"crossref","first-page":"ra9","DOI":"10.1126\/scisignal.2004754","article-title":"The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris","volume":"7","author":"Martina","year":"2014","journal-title":"Sci. Signal"},{"key":"10.1016\/j.prp.2023.154313_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-cancerbio-030518-055835","article-title":"MiT\/TFE family of transcription factors, lysosomes, and cancer","volume":"3","author":"Perera","year":"2019","journal-title":"Annu Rev. Cancer Biol."},{"key":"10.1016\/j.prp.2023.154313_bib37","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/PAS.0b013e31827e17cb","article-title":"TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum","volume":"37","author":"Rao","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib38","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/PAS.0b013e31828a69ae","article-title":"Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service","volume":"37","author":"Green","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/PAS.0b013e3181dd577e","article-title":"Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma","volume":"34","author":"Zhong","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154313_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/PDM.0b013e31820e9c67","article-title":"Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas","volume":"20","author":"Mosquera","year":"2011","journal-title":"Diagn. Mol. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823000134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:54:48Z","timestamp":1759733688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823000134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":40,"alternative-id":["S0344033823000134"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154313","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TFE3-immunopositive papillary renal cell carcinoma: A clinicopathological, immunohistochemical, and genetic study","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154313"}}